ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
39 988,22
0,30%
DAX
18 704,42
-0,11%
Brent Oil
83,775
0,69%
Bitcoin
67 017,67
2,73%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Proteon Therapeutics Inc (PRTO)

  7. Proteon Therapeutics Inc (PRTO) Actualités

PRTO

Proteon Therapeutics (PRTO)

Proteon Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRTO
DateHeureSourceTitreSymboleSociété
21/01/202023h16Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PRTOProteon Therapeutics Inc
17/01/202022h10Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRTOProteon Therapeutics Inc
16/01/202014h01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRTOProteon Therapeutics Inc
15/01/202012h04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PRTOProteon Therapeutics Inc
14/01/202000h56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PRTOProteon Therapeutics Inc
14/01/202000h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRTOProteon Therapeutics Inc
10/01/202023h26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRTOProteon Therapeutics Inc
09/01/202019h43GlobeNewswire Inc.ArTara Therapeutics Completes Merger Transaction with Proteon TherapeuticsNASDAQ:PRTOProteon Therapeutics Inc
31/12/201922h05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PRTOProteon Therapeutics Inc
20/12/201922h06Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:PRTOProteon Therapeutics Inc
20/12/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRTOProteon Therapeutics Inc
19/12/201922h26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PRTOProteon Therapeutics Inc
18/12/201923h46Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:PRTOProteon Therapeutics Inc
03/12/201923h45PR Newswire (US)Moore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina T...NASDAQ:PRTOProteon Therapeutics Inc
22/11/201916h37PR Newswire (US)Moore Kuehn, PLLC Encourages Vitamin Shoppe, Inc. (VSI), Jagged Peak Energy Inc. (JAG), Proteon Therapeutics, Inc. (PRTO), an...NASDAQ:PRTOProteon Therapeutics Inc
21/11/201923h33PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Proteon Therapeutics, Inc.NASDAQ:PRTOProteon Therapeutics Inc
07/11/201912h09Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:PRTOProteon Therapeutics Inc
31/10/201922h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PRTOProteon Therapeutics Inc
23/09/201922h20GlobeNewswire Inc.Proteon Therapeutics and ArTara Therapeutics Agree to CombineNASDAQ:PRTOProteon Therapeutics Inc
07/08/201914h00GlobeNewswire Inc.Proteon Therapeutics Announces Second Quarter 2019 Financial ResultsNASDAQ:PRTOProteon Therapeutics Inc
08/05/201914h00GlobeNewswire Inc.Proteon Therapeutics Announces First Quarter 2019 Financial ResultsNASDAQ:PRTOProteon Therapeutics Inc
15/04/201922h30GlobeNewswire Inc.Proteon Therapeutics Announces Review of Potential Strategic TransactionsNASDAQ:PRTOProteon Therapeutics Inc
12/04/201914h11Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PRTOProteon Therapeutics Inc
28/03/201913h00GlobeNewswire Inc.Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteri...NASDAQ:PRTOProteon Therapeutics Inc
14/03/201922h06Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:PRTOProteon Therapeutics Inc
13/03/201913h03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PRTOProteon Therapeutics Inc
13/03/201913h00GlobeNewswire Inc.Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial ResultsNASDAQ:PRTOProteon Therapeutics Inc
04/03/201922h30GlobeNewswire Inc.Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11thNASDAQ:PRTOProteon Therapeutics Inc
24/01/201914h00GlobeNewswire Inc.Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase i...NASDAQ:PRTOProteon Therapeutics Inc
18/12/201814h41Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PRTOProteon Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PRTO

Dernières Valeurs Consultées

NYSE
NETC.U
Nabors Energy Transition
LSE
GBO
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés